Open AccessResponse to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912–1920
Author(s) -
Michael A. Nauck,
Eskil Kreiner,
Søren Rasmussen,
Hans A. Saevereid,
John B. Buse
Publication year - 2020
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dci19-0067
Subject(s) - medicine , liraglutide , gallbladder , placebo , gastroenterology , hazard ratio , biliary colic , diabetes mellitus , cholecystitis , gallbladder disease , biliary tract , type 2 diabetes , proportional hazards model , cholecystectomy , endocrinology , pathology , alternative medicine , confidence interval
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom